BPMC — Blueprint Medicines Corp

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $129.46 Analyst target: $130.29 Upside: 0.64%

See the full interactive analysis & chart →

Informational only — not investment advice.